Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa, Piyada, Zhou, Daming, Dejnirattisai, Wanwisa, Liu, Chang, Mentzer, Alexander J., Ginn, Helen M., Zhao, Yuguang, Duyvesteyn, Helen M.E. +45 more·2021·Cell
DOI 10.1016/j.cell.2021.02.033

Cited by (461)

Items 301–400 of 461

  1. COVID ‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
    Ana Paula Hitomi Yokoyama, Silvano Wendel, Carolina Bonet Bub, Roberta Maria Fachini, Ana Paula F. Dametto, Fernando Sérgio Blumm Ferreira, Valéria de Freitas Dutra, Gabriela de Toledo Passos Candelaria, Araci Massami Sakashita, Rafael Rahal Guaragna Machado et al. · 2021 · Transfusion
  2. Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
    Katharina Müller, Philipp Girl, Andreas Giebl, Heiner von Buttlar, Gerhard Dobler, Joachim J. Bugert, Stefanie Grützner, Roman Wölfel · 2021 · Journal of Clinical Virology
  3. Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate
    Shirley Gee Hoon Tang, Muhamad Haziq Hasnul Hadi, Siti Rosilah Arsad, Pin Jern Ker, Santhi Ramanathan, Nayli Aliah Mohd Afandi, Madihah Mohd Afzal, Mei Wyin Yaw, Prajindra Sankar Krishnan, Chai Phing Chen et al. · 2022 · International Journal of Environmental Research and Public Health
  4. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2
    Elena G. Geromichalou, George D. Geromichalos · 2022 · Molecules
  5. Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses ( SARS‐CoV ‐1 and SARS‐CoV ‐2)
    Agnieszka Rombel‐Bryzek, Adriana Miller, Danuta Witkowska · 2022 · FEBS Open Bio
  6. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
    Nawal Al Kaabi, Yunkai Yang, Salah Eldin Hussein, Tian Yang, Jehad Abdalla, Hui Wang, Zhiyong Lou, Agyad Ebrahim Bakkour, Afnan Arafat, Zhiwei Jiang et al. · 2023 · Vaccines
  7. Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
    Pantelis Poumbourios, Christine Langer, Irene Boo, Tasnim Zakir, Anouschka Akerman, Vanessa Milogiannakis, Anupriya Aggarwal, Bronte A. Johnstone, Jungmin Ha, Fasséli Coulibaly et al. · 2023 · PLoS Pathogens
  8. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology, and Variants of Concern
    Paul C. Guest, Prashant Kesharwani, Alexandra E. Butler, Amirhossein Sahebkar · 2023 · Advances in experimental medicine and biology
  9. Interferon-inducible guanylate-binding protein 5 inhibits replication of multiple viruses by binding to the oligosaccharyltransferase complex and inhibiting glycoprotein maturation
    Shaobo Wang, Wanyu Li, Jing Wen, Lingling Wang, Shashi Kant Tiwari, William Bray, Lujing Wu, Na Li, Hui Hui, Alex E. Clark et al. · 2025 · mBio
  10. Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges
    Giovanni Corrao, Guido Bertolaso, Giovanni Pavesi, Letizia Moratti · 2022 · International Journal of Environmental Research and Public Health
  11. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant
    Albert To, Teri Ann S. Wong, Michael M. Lieberman, Karen Sue Thompson, Aquena H. Ball, Laurent Pessaint, Jack J. Greenhouse, Nisrine Daham, Anthony Cook, Brandon Narvaez et al. · 2022 · ACS Infectious Diseases
  12. Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination
    Floriana Bonura, Dario Genovese, Emanuele Amodio, Giuseppe Calamusa, Giuseppa Luisa Sanfilippo, Federica Cacioppo, Anna Giammanco, Simona De Grazia, Donatella Ferraro · 2022 · Vaccines
  13. Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
    Tyler M. Brady, Tianhui Zhang, Kevin M. Tuffy, Nantaporn Haskins, Qun Du, Jia Lin, Gilad Kaplan, Steven J. Novick, Tiffany L. Roe, Kuishu Ren et al. · 2022 · Microbiology Spectrum
  14. The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses
    Lu Zhang, Hongquan Chen, Su Lan Yang, Yang Zhao, Xiaoyun Y. Shen, Xiaowen He, Haohui Ye, Deqin Wang, Jiazhou Lou, Yinshan Wang et al. · 2022 · Frontiers in Immunology
  15. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study
    Shi Zhao, Jinjun Ran, Lefei Han · 2021 · American Journal of Tropical Medicine and Hygiene
  16. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
    Blake Marie Hauser, Maya Sangesland, Kerri St. Denis, Ian W. Windsor, Jared E. Feldman, Evan Christopher Lam, Ty Kannegieter, Alejandro Benjamin Balazs, Daniel Lingwood, Aaron G. Schmidt · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation
    Ramachandran Thiruvengadam, Amit Awasthi, Guruprasad R. Medigeshi, Sankar Bhattacharya, Shailendra Mani, Sridhar Sivasubbu, Tripti Srivatsava, Sweety Samal, Deepika Rathna Murugesan, Bapu Koundinya Desiraju et al. · 2021 · SSRN Electronic Journal
  18. Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike
    Helen M. E. Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, Piyada Supasa, Barbara Kronsteiner, Katie JM Jeffery, Lizzie Stafford, Paul Klenerman, Susanna Jane Dunachie, Juthathip Mongkolsapaya et al. · 2024 · Structure
  19. Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 Lineage
    Dieter De Smet, Merijn Vanhee, Brigitte Maes, Koen Swaerts, Peter De Jaeger, Karel Maelegheer, Frederik Van Hoecke, Geert Antoine Martens · 2021 · American Journal of Clinical Pathology
  20. Specific CD8+ TCR Repertoire Recognizing Conserved Antigens of SARS-CoV-2 in Unexposed Population: A Prerequisite for Broad-Spectrum CD8+ T Cell Immunity
    Wei Hu, Meifang He, Xiaoning Wang, Qiang Sun, Ming Kuang · 2021 · Vaccines
  21. A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants
    Paroma Deb, Md. Maruf Ahmed Molla, KM Saif‐Ur‐Rahman, Manik Chandra Das, Debashish Das · 2021 · Egyptian Journal of Bronchology
  22. Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity
    Saina Beitari, Diana Duque, Jegarubee Bavananthasivam, Melissa Hewitt, Jagdeep K. Sandhu, Ita Hadžisejdić, Anh Tran · 2023 · Virology Journal
  23. Structure, dynamics and free energy studies on the effect of point mutations on SARS-CoV-2 spike protein binding with ACE2 receptor
    George Rucker, Hong Qin, Liqun Zhang · 2023 · PLoS ONE
  24. Susceptibility to SARS-CoV-2 Virus Variants of Concern in Mouse Models
    Andrey V. Shipovalov, Gleb A. Kudrov, Алексей Томилов, С. А. Боднев, Nikita D. Boldyrev, Alena S. Ovchinnikova, A. V. Zaikovskaya, Oleg Svyatoslavovich Taranov, Oleg V. Pyankov, R. A. Maksyutov · 2022 · Problems of Particularly Dangerous Infections
  25. SARS-CoV-2 variants from COVID-19 positive cases in the Free State province, South Africa from July 2020 to December 2021
    Peter N. Mwangi, Javan Okendo, Milton T. Mogotsi, Ayodeji Emmanuel Ogunbayo, Olusesan Adeyemi Adelabu, Hlengiwe Sondlane, Makgotso Golda Maotoana, Lutfiyya Mahomed, Molefi Daniel Morobadi, Sabeehah Vawda et al. · 2022 · Frontiers in Virology
  26. Exploration of spectroscopic, computational, fluorescence turn-off mechanism, molecular docking and in silico studies of pyridine derivative
    Raveendra M. Melavanki, Raviraj A. Kusanur, Kalpana Sharma, Kishor Kumar Sadasivuni, Varsha V. Koppal, Ninganagouda R. Patil · 2023 · Photochemical & Photobiological Sciences
  27. Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2
    Rodrigo Lázaro‐Gorines, Patricia Pérez, Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Guillermo Albericio, David Astorgano, Sara Flores, Joanna Luczkowiak, Nuria Labiod, Seandean L. Harwood et al. · 2023 · Advanced Science
  28. Applications of peptide-functionalized or unfunctionalized selenium nanoparticles for the passivation of SARS-CoV-2 variants and the respiratory syncytial virus (RSV)
    Alaa F. Nahhas, Thomas Jay Webster · 2023 · Colloids and Surfaces B Biointerfaces
  29. Molecular Dynamics Simulations on Spike Protein Mutants Binding with Human β Defensin Type 2
    Liqun Zhang, Jadeson Li · 2024 · The Journal of Physical Chemistry B
  30. Zoonotic and anthropozoonotic potential of COVID-19 and its implications for public health
    Amr El-Sayed, Mohamed M. Abdel‐Daim, Mohamed Salah Kamel · 2021 · Environmental Science and Pollution Research
  31. SARS-CoV-2 transmissibility compared between variants of concern and vaccination status
    Liang Wang, Xavier Didelot, Yuhai Bi, George F. Gao · 2021 · Briefings in Bioinformatics
  32. An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives
    Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, Rahul Kumar Gupta, Rajveer Singh, Rudra Chakravarti, V. Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh, Syamal Roy · 2022 · RSC Medicinal Chemistry
  33. Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19
    Paulina Kapłonek, Deniz Cizmeci, Jessica Shih-Lu Lee, Sally A. Shin, Stephanie Fischinger, Philipe Gobeil, Stéphane Pillet, Nathalie Charland, Brian J. Ward, Galit Alter · 2023 · npj Vaccines
  34. Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta
    Nídia S. Trovão, Vincent Pan, Chirag Goel, Pilar Gallego‐García, Yunxi Liu, Christopher Barbara, Rebecca Borg, Mark Briffa, Chanelle Cilia, Laura Grech et al. · 2023 · Microbiology Spectrum
  35. Comparison of IgA, IgG and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 vaccines.
    Tomabu Adjobimey, Julia Meyer, Leander Sollberg, Michael Bawolt, Christina Berens, Peđja Kovačević, Anika Trudić, Marijo Parčina, Achim M. Hoerauf · 2021 · Research Square
  36. Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021
    Yvonne C. F. Su, Michael A. Zeller, Tey Putita Ou, Jordan Ma, Leakhena Pum, Rong Zhang, Sophannadeth Rath, Vireak Heang, Sonita Kol, Reaksa Lim et al. · 2024 · Communications Medicine
  37. Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
    Ying Lu, An‐Qi Li, Fan Shen, Wenqiang He, Shu‐Heng Yu, Yan‐Bo Zhao, Xiaoli Feng, Minghua Li, Songying Ouyang, Yong‐Tang Zheng et al. · 2025 · MedComm
  38. Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
    Huijie Yang, Ying Xie, Shuaiyao Lu, Yufang Sun, Kaiqin Wang, Shuyan Li, Junzhi Wang, Guoyang Liao, Changgui Li · 2023 · Vaccines
  39. Impact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study
    Agnieszka Rombel‐Bryzek, P. Petkov, Elena Lilkova, Nevena Ilieva, L. Litov, Mariusz Kubus, Danuta Witkowska · 2025 · International Journal of Molecular Sciences
  40. Evaluation of phytoconstituents of Tinospora cordifolia against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study
    Princy Choudhary, Tanu Singh, Ayush Amod, Sangeeta Singh · 2022 · Journal of Biomolecular Structure and Dynamics
  41. Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
    Ileanet Avalos, Thailin Lao, Elsa Rodríguez Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn C. Ramòn, Gilda Lemos, Ania Cabrales, Mónica Béquet‐Romero, Dionne Casillas et al. · 2022 · Vaccines
  42. The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
    W. Tolbert, Yao-Zong Chen, Lu-Lu Sun, M. Benlarbi, Shi-Lei Ding, Rohini Manickam, Emily Pangaro, Dung N. Nguyen, Suneetha Gottumukkala, M. Côté et al. · 2023 · Frontiers in Immunology
  43. Mapping Genetic Events of SARS-CoV-2 Variants
    Luyao Qin, Jing Meng, Xiao Lan Ding, Taijiao Jiang · 2022 · Frontiers in Microbiology
  44. Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
    Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Thanunrat Thongmee, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Ritthideach Yorsaeng, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon et al. · 2024 · Vaccines
  45. Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals
    Aurélien Sokal, Giovanna Barba Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andrea de La Selle, Alexis Vandenberghe, Slim Fourati, Anaïs Roeser, Annalisa Meola et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Role of N501Y Mutation in SARS-CoV-2 Spike Protein Structure
    Urmi Roy · 2021 · Preprints.org
  47. SARS-CoV-2 spike RBD and nucleocapsid encoding DNA vaccine elicits T cell and neutralising antibody responses that cross react with variants
    Victoria A. Brentville, M Vankemmelbeke, Rachael L. Metheringham, P Symonds, KW Cook, Richard A. Urbanowicz, Theocharis Tsoleridis, CM Coleman, K-C Chang, A Skinner et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
    Mary E. Petrone, Carolina Gonçalves de Oliveira Lucas, Bridget L. Menasché, Mallery I. Breban, Inci B. Yildirim, Melissa Campbell, Saad B. Omer, Albert Icksang Ko, Nathan D. Grubaugh, Akiko Iwasaki et al. · 2022 · medRxiv
  49. Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
    Manon Ragonnet‐Cronin, Rungtiwa Nutalai, Jiandong Huo, Aiste Dijokaite-Guraliuc, Raksha Das, Aekkachai Tuekprakhon, Piyada Supasa, Chang Liu, Muneeswaran Selvaraj, Natalie Groves et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  50. ARNLE model identifies prevalence potential of SARS-CoV-2 variants
    Yuqi Liu, Jing Li, Peihan Li, Kaiying Wang, Kaiying Wang, Jinhui Li, Lang Yang, Jiangfeng Liu, Leili Jia, Aiping Wu et al. · 2024 · Nature Machine Intelligence
  51. Comprehensive review on emerging nanotechnologies for combating COVID-19 and future pandemic preparedness
    ZuanLei Liang, Guangcun Shan, Shizhe Shan, Zejian Ding, Jiliang Zhang, Bingfeng Chu · 2025 · International Journal of Pharmaceutics
  52. An Electrostatically-steered Conformational Selection Mechanism Promotes SARS-CoV-2 Spike Protein Variation
    Marija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Rodrigues, Panagiotis L. Kastritis · 2022 · Journal of Molecular Biology
  53. SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
    Rike Syahniar, Dayu Swasti Kharisma · 2022 · Clinical and Experimental Vaccine Research
  54. A bibliometric analysis of the 100 most cited articles describing SARS-CoV-2 variants
    Ya-Hui Zhang, Mei-Jing Feng, Yong-Mei He, Fang-Ming Liu, Rui Ma · 2022 · Frontiers in Public Health
  55. Microfluidic Diffusion Sizing Applied to the Study of Natural Products and Extracts That Modulate the SARS-CoV-2 Spike RBD/ACE2 Interaction
    Jason Fauquet, Julie Carette, Pierre Duez, Jiu‐liang Zhang, Amandine Nachtergael · 2023 · Molecules
  56. Analysis of the immune response in COVID-19
    Altijana Hromić‐Jahjefendić, Alaa A. A. Aljabali · 2025 · Progress in molecular biology and translational science
  57. Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
    Hardeep Singh Tuli, Katrin Sak, Poonam Aggarwal, Ashif Iqubal, Sushil K. Upadhaya, Jagjit Kaur, Ginpreet Kaur, Diwakar Aggarwal · 2021 · Frontiers in Cellular and Infection Microbiology
  58. Accuracy of Allplex SARS-CoV-2 Assay Amplification Curve Analysis for the detection of SARS-CoV-2 Variant Alpha
    Tjaša Žohar Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, Barbara Jenko Bizjan, Samo Jeverica, Mateja Ravnik, Mitja Rak et al. · 2022 · Future Microbiology
  59. Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
    AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Pritha Ghosh, Rohit Suratekar, Eli Silvert, Colin Pawlowski, Abhishek Siroha, Dibyendu Roy Chowdhury, John Charles O’Horo et al. · 2023 · Scientific Reports
  60. SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
    Jianhua Li, Xiaoyan Li, Haiyan Mao, Chen Huang, Yi Sun, Liangbin Miao, Jiaxuan Li, Wanchen Song, Yanjun Zhang, Jinsong Huang et al. · 2023 · Virus Research
  61. Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19
    Fabio Pisano, B. Cannas, Alessandra Fanni, Manuela Pasella, Beatrice Canetto, Sabrina Giglio, Stefano Mocci, Luchino Chessa, Andrea Perra, Roberto Littera · 2023 · Frontiers in Medicine
  62. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
  63. Neutralization assays for SARS-CoV-2
    Labanya Mukhopadhyay, Nivedita Gupta, Pragya Dhruv Yadav, Neeraj Aggarwal · 2022 · The Indian Journal of Medical Research
  64. The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs
    Wenqiang Sun, Lihong He, Huicong Lou, Wenhui Fan, Limin Yang, Gong Cheng, Wenjun Liu, Lei Sun · 2022 · Frontiers in Immunology
  65. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
    Alexander J. Pak, Alvin Yu, Zunlong Ke, John A. G. Briggs, Gregory A. Voth · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Structural and computational insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
    Xinquan Wang, Jun Lan, Xinheng He, Yifei Ren, Ziyi Wang, Huan Zhou, Shilong Fan, Chenyou Zhu, Dongsheng Liu, Bin Shao et al. · 2022 · Research Square
  67. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
    Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, Ricardo B. Parsons, Donald J. Benton, Chloë Roustan, Eamonn Reading et al. · 2022 · Research Square
  68. Structure, Dynamics and Free Energy Studies on the Effect of Spot Mutations on SARS-CoV-2 Spike Protein Binding with ACE2 Receptor
    George Rucker, Hong Qin, Liqun Zhang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice
    Jianping Li, Kevin S. Hsu, Savannah E. Howe, Tanya N. Hoang, Xia Zheng, Jay A. Berzofsky, Yongjun Sui · 2024 · Frontiers in Immunology
  70. Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization
    Amit K. Maiti · 2024 · International Journal of Molecular Sciences
  71. MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
    Sua Lee, ShinA Jang, Ji‐Hoon Kang, Soo Bin Park, Young Woo Han, Hyemi Nam, Munkyung Kim, Jeewon Lee, Ki Joon Cho, Jeonghun Kim et al. · 2021 · Frontiers in Immunology
  72. Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study
    Hakjun Hyun, Min Joo Choi, Jung Yeon Heo, Yu Bin Seo, Eliel Nham, Jin Gu Yoon, Hye Seong, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim et al. · 2022 · Journal of Korean Medical Science
  73. Collaborative effects of 2019-nCoV-Spike mutants on viral infectivity
    Senbiao Fang, Chuqi Lei, Meng Li, Yongfan Ming, Liren Liu, Xuming Zhou, Min Li · 2023 · Computational and Structural Biotechnology Journal
  74. Importance of Timely Sequencing, Tracking, and Surveillance of Emergent Variants
    Jessica Lin, Morgan N. Greenleaf, Yang Lu, Leda Bassit, Cassandra Wesselman, Anne L Piantadosi · 2024 · Cambridge University Press eBooks
  75. Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study
    Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Lakkhana Wongsrisang, Ratchadawan Aeemjinda, Preeyaporn Vichaiwattana, Thaksaporn Thatsanathorn, Warangkana Chantima, Pattarakul Pakchotanon, Thaneeya Duangchinda et al. · 2024 · Vaccine X
  76. Impact of Second Wave of COVID-19 on Health Care Workers in India
    Karthikeyan Parthasarathy Iyengar, Vijay Kumar Jain, Pranav Ish, Raju Vaishya · 2021 · Apollo Medicine
  77. How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling system
    Dana Ashoor, Maryam Marzouq, Khaled Trabelsi, Sadok Chlif, Nasser Abotalib, Noureddine Ben Khalaf, Ahmed R. Ramadan, M. Dahmani Fathallah · 2022 · Frontiers in Cellular and Infection Microbiology
  78. B cell receptor (BCR) guided mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping
    Kabeer Haneef, Abdul Ghaffar Memon, Rabia Saleem, Farwa Batool, Mohd Sadeeq · 2021 · Medical Hypotheses
  79. Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
    Anni Ge, Melissa L. Rioux, Alyson A. Kelvin · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Impact of glycosylation on a broad-spectrum vaccine against SARS-CoV-2
    Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, Szu-Wen Wang, Cheng-Wei Cheng, Md. Shahed-Al-Mahmud, Ting-Hua Chen, Jennifer M. Lo, Yo-Min Liu, Yimin Wu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Data-driven approaches for genetic characterization of SARS-CoV-2 lineages
    Fatima Mostefai, Isabel Gamache, Jessie Huang, Arnaud N’Guessan, Justin Pelletier, Ahmad Pesaranghader, David J. Hamelin, Carmen Lía Murall, Raphaël Poujol, Jean‐Christophe Grenier et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Prior SARS-CoV2 infection in vaccinated solid organ transplant recipients induces potent neutralization responses against variants, including Omicron
    A. Choudhary, M. Lerman, David Calianese, Salman Khan, J. Hunt, A. Nikaein, W. Honnen, D. Jaijyan, E. Kalu, Abraham Pinter · 2022 · medRxiv
  83. Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2
    Hengrui Hu, Chao Leng, Yanni Shu, Peng Lü, Fan Wu, Jia Liu, Xiaolu Zhang, Wei Zhou, Qinghong Xiao, Yufeng Li et al. · 2025 · Journal of Virology
  84. Real-time quantification of the transmission advantage associated with a single mutation in pathogen genomes: a case study on the D614G substitution of SARS-CoV-2
    Shi Zhao, Jingzhi Lou, Lirong Cao, Hong Zheng, Ka Chun Chong, Zigui Chen, Renee W. Y. Chan, Benny Chung-Ying Zee, Paul K.S. Chan, Maggie Haitian Wang · 2021 · BMC Infectious Diseases
  85. Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses.
    Abdellatif Bouayad · 2023 · PubMed Central
  86. Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
    Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, Brijesh Pandey, Thakur Prasad Yadav, Satarudra Prakash Singh · 2024 · MedComm – Future Medicine
  87. A case of reinfection with a different variant of SARS-CoV-2: case report
    Nagashige Shimada, Masahiro Shinoda, Hiroaki Takei, Yuto Yoshida, Masashi Nishimura, Mio Kousaka, Miwa Morikawa, Takashi Sato, Hiroto Matsuse, Masaharu Shinkai · 2023 · The Egyptian Journal of Internal Medicine
  88. Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
    Blake Marie Hauser, Maya Sangesland, Evan Christopher Lam, Jared E. Feldman, Alejandro Benjamin Balazs, Daniel Lingwood, Aaron G. Schmidt · 2022 · Frontiers in Immunology
  89. Effect on the conformations of the spike protein of SARS‐CoV‐2 due to mutation
    Aayatti Mallick Gupta, J. Chakrabarti · 2022 · Biotechnology and Applied Biochemistry
  90. Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants
    Mary E. Petrone, Carolina Gonçalves de Oliveira Lucas, Bridget L. Menasché, Mallery I. Breban, Inci B. Yildirim, Melissa Campbell, Saad B. Omer, Edward Charles Holmes, Albert Icksang Ko, Nathan D. Grubaugh et al. · 2023 · Genome Biology and Evolution
  91. Mutations in two SARS-CoV-2 variants of concern reflect two distinct strategies of antibody escape
    Sebastian Fiedler, Viola Denninger, Alexey S. Morgunov, Alison Ilsley, Roland Worth, Georg Meisl, Catherine K. Xu, Monika A. Piziorska, Francesco Ricci, Anisa Y. Malik et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line
    Daniela Niemeyer, Simon Schroeder, Kirstin Friedmann, Friderike Weege, Jakob Trimpert, Anja M. Richter, Saskia Stenzel, Jenny Jansen, Jackson Emanuel, Julia Kazmierski et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Immunity Escape of SARS-CoV-2 Variants: Omicron Leads the Way
    Rupali Dhingra, Aarjoo Sharma, Sanjeev Balda, Anshika Billa, Shiv Nandan Sah, Neena Capalash, Prince Sharma · 2022 · Preprints.org
  94. A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
    Chen Chen, Veda Sheersh Boorla, Ratul Chowdhury, Ruth Helmus Nissly, Abhinay Gontu, Shubhada K. Chothe, Lindsey Cecelia LaBella, Padmaja Jakka, Santhamani Ramasamy, Kurt J. Vandegrift et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  95. High-throughput molecular dynamics-based alchemical free energy calculations for predicting the binding free energy change associated with the common mutations in the spike receptor-binding domain of SARS-CoV-2
    Rajendra N. Bhadane, Outi M. H. Salo‐Ahen · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
    Jernej Pušnik, Julia König, Karola Mai, Enrico Richter, Jasmin Zorn, Hannah Proksch, Bianca Schulte, Galit Alter, Hendrik Streeck · 2022 · SSRN Electronic Journal
  97. Comprehensive Mapping of Binding Hot Spots of SARS-CoV-2 RBD-specific Neutralizing Antibodies for Tracking Immune Escape Variants
    Chunyan Yi, Xiaoyu Sun, Yixiao Lin, Chenjian Gu, Longfei Ding, Xiao Ping Lu, Zhuo Yi Yang, Yaguang Zhang, Liyan Ma, Wangpeng Gu et al. · 2021 · Research Square
  98. Role of prior immunity in binding to spike of “future” Omicron subvariants
    Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, Sangeetha Priya, Rohini Ramachandran, Sevanthy Suresh, Tamil Venthan Mathivanan, Nelson Vijaykumar Balu, Kavitha Selvaraj, Arun Jose Nellickal et al. · 2024 · Indian Journal of Medical Microbiology
  99. Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus
    Bekbolat S. Usserbayev, Kulyaisan T. Sultankulova, Yerbol D. Burashev, Aibarys M. Melisbek, Meirzhan Shirinbekov, Balzhan Sh. Myrzakhmetova, Izat Smekenov, Asankadir Zhunushov, Керимбаев Аслан Амангельдиевич, Sergazy Sh. Nurabayev et al. · 2025 · Viruses
  100. Fatores de virulência microbianos e terapias emergentes
    Amanda Virgínia Barbosa, Sivoneide Maria da Silva, Francisco Henrique S. da Silva, Matheus Alves Siqueira de Assunção, Fálba Bernadete Ramos dos Anjos · 2022 · Latin American Publicações eBooks